1. Endothelial Cells (ECs) Metabolism: A Valuable Piece to Disentangle Cancer Biology
   Filipa Lopes-Coelho et al, 2020, Tumor Microenvironment CrossRef
2. Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment
   Wenxin Xu et al, 2023, Cellular Reprogramming CrossRef
3. PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-κB Signaling Pathway in Ovarian Cancer
   Yu-xin Jiang et al, 2022, Frontiers in Oncology CrossRef
4. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer
   Libin Ma et al, 2020, Aging CrossRef
5. Construction of Glycolytic Regulator Gene Signature to Predict the Prognosis and Tumor Immune Cell Infiltration Levels for Prostate Cancer
   Ling Zhang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
6. Emerging roles of aerobic glycolysis in breast cancer
   Z. Wu et al, 2020, Clinical and Translational Oncology CrossRef
7. Exploring the Cardioprotective Effects of Pharmacological Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6- Bisphosphatase-3 in Ischemia-Reperfusion-Subjected Rats
   Jingjing Han et al, 2022, International Journal of Pharmacology CrossRef
8. Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes
   Xiaoping Li et al, 2020, PeerJ CrossRef
9. Nuances of PFKFB3 Signaling in Breast Cancer
   Claudia Martins Galindo et al, 2022, Clinical Breast Cancer CrossRef
10. Size-Specific Modulation of a Multienzyme Glucosome Assembly during the Cell Cycle
    Miji Jeon et al, 2023, ACS Bio & Med Chem Au CrossRef
11. Glucose Metabolism and Glucose Transporters in Breast Cancer
    Eunah Shin et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
12. Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation
    Carlotta Boscaro et al, 2020, Frontiers in Pharmacology CrossRef
13. Targeting T Cell Metabolism as a Novel Approach for Treatment of MS: With a Focus on PFKFB3 Inhibitors
    Mahsa Eshkevar Vakili et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
14. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
    Jiao Feng et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
15. Exploring the Cardioprotective Effects of Pharmacological Inhibitors of PFKFB3 in Ischemia-Reperfusion-Subjected Rats
    Peng Deng et al, 2022, International Journal of Pharmacology CrossRef
16. KAN0438757: A NOVEL PFKFB3 INHIBITOR THAT INDUCES PROGRAMMED CELL DEATH AND SUPPRESSES CELL MIGRATION IN NON-SMALL CELL LUNG CARCINOMA CELLS
    null null et al, 2023, Biotechnologia Acta CrossRef